Stocks and Investing Stocks and Investing
Wed, June 8, 2022
[ 12:00 AM ] - WOPRAI
Michael Pachter Maintained (TTWO) at Buy with Increased Target to $162 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
Chris Carey Maintained (STZ) at Buy with Increased Target to $280 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
Neil Mehta Maintained (XOM) at Strong Buy with Increased Target to $117 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
Simon Clinch Maintained (SPGI) at Hold with Decreased Target to $375 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
Bill Chappell Downgraded (SMG) to Hold and Decreased Target to $85 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
George Iwanyc Maintained (SMAR) at Buy with Decreased Target to $65 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
Pinjalim Bora Maintained (SMAR) at Buy with Decreased Target to $58 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
Rishi Jaluria Maintained (SMAR) at Hold with Increased Target to $38 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
Stan Zlotsky Maintained (SMAR) at Buy with Decreased Target to $68 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
Keith Bachman Maintained (SMAR) at Buy with Decreased Target to $43 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
Jamie Rollo Maintained (CCL) at Sell with Decreased Target to $13 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
Kashy Harrison Initiated (BE) at Hold and Held Target at $20 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
David Anderson Maintained (BKR) at Buy with Increased Target to $47 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
Kashy Harrison Initiated (BLDP) at Sell and Held Target at $5 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
Daniel Salmon Maintained (AMZN) at Buy and Held Target at $173 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
Colin Canfield Downgraded (BAH) to Hold on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
John Ivankoe Downgraded (BROS) to Hold and Held Target at $40 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
Irene Nattel Maintained (CASY) at Hold with Decreased Target to $238 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
Jon Tower Maintained (CBRL) at Strong Sell with Decreased Target to $89 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
Jake Bartlett Maintained (CBRL) at Hold with Decreased Target to $104 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
Brett Levy Maintained (CBRL) at Hold with Decreased Target to $110 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
Michael Legg Initiated (CAN) at Strong Buy and Held Target at $9 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
Matthew Murphy Maintained (AEM) at Buy with Decreased Target to $70 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
Atidrip Modak Initiated (WFRD) at Strong Buy and Held Target at $43 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
James Hubbard Initiated (WFRD) at Strong Buy and Held Target at $49 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
Anthony Crowdell Maintained (WEC) at Hold with Increased Target to $107 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
Zachary Fadem Maintained (W) at Sell with Decreased Target to $50 on, Jun 8th, 2022
[ 12:00 AM ] - WOPRAI
Brian McKenna Initiated (ARES) at Hold on, Jun 8th, 2022
Tue, June 7, 2022
[ 12:00 AM ] - WOPRAI
Chris LaFemina Upgraded (ARCH) to Strong Buy and Increased Target to $225 on, Jun 7th, 2022
[ 12:00 AM ] - WOPRAI
David Lebowitz Maintained (ARQT) at Buy with Increased Target to $39 on, Jun 7th, 2022

David Lebowitz Maintained (ARQT) at Buy with Increased Target to $39 on, Jun 7th, 2022


Published on 2024-10-27 21:26:24 - WOPRAI, David Lebowitz
  Print publication without navigation


David Lebowitz of Morgan Stanley, Maintained "Arcutis Biotherapeutics, Inc." (ARQT) at Buy with Increased Target from $36 to $39 on, Jun 7th, 2022.

David has made no other calls on ARQT in the last 4 months.



There is 1 other peer that has a rating on ARQT. Out of the 1 peers that are also analyzing ARQT, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David

  • Uy Ear of "Mizuho" Maintained at Strong Buy with Decreased Target to $57 on, Thursday, April 7th, 2022
Contributing Sources